Physician profile
David L Johnson
NPI 1871577726
$1,851.88
in general payments reported to CMS, 2019-2025
23 companies · $62.12 in 2025
The $62.12 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $996 · 2022: $794 · 2025: $62.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $62.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $62.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $292.74 | 2021-2025 | |
| Boston Scientific Corporation | $243.55 | 2021-2025 | General - Therapies |
| Abbott Laboratories | $140.95 | 2021-2025 | Eterna |
| Amgen INC. | $121.55 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $103.79 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $92.99 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $91.04 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $90.72 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $79.03 | 2022 | |
| Scilex Pharmaceuticals INC. | $77.57 | 2022 | |
| Lilly USA, LLC | $77.31 | 2021-2022 | |
| Grt US Holding, INC. | $73.15 | 2022 | |
| Almatica Pharma LLC | $70.73 | 2021 | |
| Virtus Pharmaceuticals LLC | $66.81 | 2021 | |
| Biodelivery Sciences International, INC. | $60.89 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $39.17 | 2021-2022 | |
| Depuy Synthes Sales INC. | $27.44 | 2022 | |
| Nalu Medical, INC. | $23.94 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $21.64 | 2022 | |
| Bioventus LLC | $20.24 | 2021 | |
| Forte Bio-Pharma LLC | $13.34 | 2022 | |
| Merck Sharp & Dohme LLC | $11.67 | 2022 | |
| Pfizer INC. | $11.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.